ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print July 24, 2008, 10.1183/09031936.00035808
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaefer, M. B.
Right arrow Articles by Mayer, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaefer, M. B.
Right arrow Articles by Mayer, K.
Eur Respir J 2008; 32:1344-1353
Copyright ©ERS Journals Ltd 2008

Peroxisome proliferator-activated receptor-{alpha} reduces inflammation and vascular leakage in a murine model of acute lung injury

M. B. Schaefer, A. Pose, J. Ott, M. Hecker, A. Behnk, R. Schulz, N. Weissmann, A. Günther, W. Seeger and K. Mayer

University of Giessen Lung Center, Medical Clinic II, Justus-Liebig-University Giessen, Giessen, Germany.

CORRESPONDENCE: K. Mayer, University of Giessen Lung Center, Medical Clinic II, Justus-Liebig-University Giessen, Klinikstr. 36, D - 35392 Giessen, Germany. Fax: 49 6419942359. E-mail: Konstantin.Mayer{at}uglc.de

Keywords: Acute lung injury, inflammation, peroxisome proliferator-activated receptor-{alpha}, vascular leakage

Received: March 9, 2008
Accepted July 11, 2008

Acute lung injury (ALI) still represents a major cause of morbidity and mortality in intensive care units. Beneficial effects have been described after activation of the peroxisome proliferator-activated receptor (PPAR)-{alpha} by fibrates such as WY 14,643 (WY) in inflammatory models. In the present study, the impact of WY was investigated in a model of endotoxin (lipopolysaccharide; LPS)-induced ALI in mice.

Intratracheal LPS challenge dose-dependently resulted in leukocyte invasion, protein leakage and release of tumour necrosis factor-{alpha} as well as macrophage inflammatory protein-2, prostaglandin E2 and thromboxane B2 into the alveolar space after 8 and 24 h. Lung ventilator compliance was reduced at both time-points. In isolated perfused mouse lungs, platelet-activating factor (PAF) induced an acute increase in pulmonary artery pressure (Ppa) and in capillary filtration coefficient (Kfc). WY significantly improved all features of ALI in vivo and blunted the increase in Kfc in isolated perfused mice lungs. In mice with genetic deletion of PPAR-{alpha}, all characteristics of ALI, Ppa, and Kfc were not significantly different from wild-type mice but WY failed to improve ALI and PAF-induced increase in Kfc.

Activation of peroxisome proliferator-activated receptor-{alpha} by WY 14,643 reduced acute lung injury and vascular leakage. Fibrates may possess beneficial effects in acute pulmonary diseases beyond their lipid-lowering capability.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
H. E. Marshall, E. N. Potts, Z. T. Kelleher, J. S. Stamler, W. M. Foster, and R. L. Auten
Protection from Lipopolysaccharide-induced Lung Injury by Augmentation of Airway S-Nitrosothiols
Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 11 - 18.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the European Respiratory Society.